Combined Benefit of Quantitative Three-Compartment Breast Image Analysis and Mammography Radiomics in the Classification of Breast Masses in a Clinical Data Set.
暂无分享,去创建一个
Karen Drukker | Heather Greenwood | Karla Kerlikowske | Bethany Niell | Maryellen L Giger | Serghei Malkov | Bo Fan | Bonnie N Joe | M. Giger | K. Kerlikowske | K. Drukker | B. Niell | B. Joe | B. Fan | S. Malkov | J. Drukteinis | Heather I. Greenwood | J. Shepherd | Jesús Ávila | Leila Kazemi | Jennifer S Drukteinis | Jesus Avila | Leila Kazemi | John Shepherd
[1] J. Boyages,et al. Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50 , 2014, Breast Cancer Research and Treatment.
[2] M. Giger,et al. Breast cancer: effectiveness of computer-aided diagnosis observer study with independent database of mammograms. , 2002, Radiology.
[3] Kenji Suzuki,et al. A dual-stage method for lesion segmentation on digital mammograms. , 2007, Medical physics.
[4] Yit Yoong Lim,et al. Accuracy of Digital Breast Tomosynthesis for Depicting Breast Cancer Subgroups in a UK Retrospective Reading Study (TOMMY Trial). , 2015, Radiology.
[5] B K Rutt,et al. Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions--implications for imaging modalities. , 1998, Radiology.
[6] Catherine M. Appleton,et al. The Future of Contrast-Enhanced Mammography. , 2017, AJR. American journal of roentgenology.
[7] J. Lewin,et al. Contrast-enhanced tomosynthesis: The best of both worlds or more of the same? , 2016, European journal of radiology.
[8] Oguzhan Alagoz,et al. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. , 2014, Journal of the National Cancer Institute.
[9] N. Houssami,et al. Rapid review: radiomics and breast cancer , 2018, Breast Cancer Research and Treatment.
[10] Erich P Huang,et al. Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set , 2016, npj Breast Cancer.
[11] R. Hubbard,et al. Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography. , 2014, Journal of the National Cancer Institute.
[12] Felix Diekmann,et al. Evaluation of contrast-enhanced digital mammography. , 2011, European journal of radiology.
[13] Lorenzo L. Pesce,et al. Reliable and computationally efficient maximum-likelihood estimation of "proper" binormal ROC curves. , 2007, Academic radiology.
[14] Erich P Huang,et al. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays. , 2016, Radiology.
[15] Maryellen L. Giger,et al. Evaluation of clinical breast MR imaging performed with prototype computer-aided diagnosis breast MR imaging workstation: reader study. , 2011, Radiology.
[16] Karen Drukker,et al. Mammographic quantitative image analysis and biologic image composition for breast lesion characterization and classification. , 2014, Medical physics.
[17] K. Mandl,et al. National expenditure for false-positive mammograms and breast cancer overdiagnoses estimated at $4 billion a year. , 2015, Health affairs.
[18] Ehsan Samei,et al. Dual-energy contrast-enhanced breast tomosynthesis: optimization of beam quality for dose and image quality , 2011, Physics in medicine and biology.
[19] Jessica W T Leung,et al. Biomarkers and Imaging of Breast Cancer. , 2017, AJR. American journal of roentgenology.
[20] B. Tromberg,et al. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. , 2006, Journal of biomedical optics.
[21] E. Kinney. Primer of Biostatistics , 1987 .
[22] Nico Karssemeijer,et al. Evaluation of the effect of computer-aided classification of benign and malignant lesions on reader performance in automated three-dimensional breast ultrasound. , 2013, Academic radiology.
[23] D. Miglioretti,et al. Cumulative Probability of False-Positive Recall or Biopsy Recommendation After 10 Years of Screening Mammography , 2011, Annals of Internal Medicine.
[24] Karla Kerlikowske,et al. Compositional breast imaging using a dual-energy mammography protocol. , 2009, Medical physics.
[25] Hiroyuki Abe,et al. Quantitative texture analysis: robustness of radiomics across two digital mammography manufacturers’ systems , 2017, Journal of medical imaging.
[26] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[27] M. Giger,et al. Multimodality computer-aided breast cancer diagnosis with FFDM and DCE-MRI. , 2010, Academic radiology.
[28] Rebecca A Hubbard,et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. , 2013, JAMA internal medicine.
[29] Paul Kinahan,et al. Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.
[30] Michael Götz,et al. Prediction of malignancy by a radiomic signature from contrast agent‐free diffusion MRI in suspicious breast lesions found on screening mammography. , 2017, Journal of magnetic resonance imaging : JMRI.
[31] D. Kopans,et al. Cumulative Probability of False-Positive Recall or Biopsy Recommendation After 10 Years of Screening Mammography: A Cohort Study , 2012 .
[32] S Friedman,et al. Prognostic value of histologic grade nuclear components of Scarff‐Bloom‐Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas , 1989, Cancer.